Organization: Eli Lilly

The Short Report – Jan. 12, 2022: Chair and vice chairs elected for standing committee on science, Order of Canada appointments, Health Canada’s 2021 cannabis survey, and more

OTTAWA Transport Canada has released updated guidelines for testing automated driving systems (ADS), which will apply to any organization conducting R&D trials of vehicles equipped with ADS. The guidelines are meant to clarify the roles and responsibilities of federal, provincial/territorial and municipal governments as they relate to trial organizations and to establish a baseline of…

Biotechnology and engineering biology roadmap plus investment are key to Canada’s economic recovery

The federal government needs to support an inclusive engineering biology ecosystem that leverages Canadian-grown capacities across industry, academia and government, Bettina Hamelin, president and CEO of Ontario Genomics, says in an editorial. Canada needs a comprehensive and aligned roadmap for a public-private partnership and investment strategy to benefit from the increasing opportunities in this emerging sector, she says.

The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more

Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…